Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdel Rahman El-Naggar"'
Autor:
Noha Salah El Baghdady, Lamia Elwakeel, Mahmoud Ellithy, Nawal Hussein, Sara Shahin, Abdel Rahman El Naggar
Publikováno v:
Archives of Pharmaceutical Sciences Ain Shams University, Vol 4, Iss 2, Pp 224-236 (2020)
Objectives: Sorafenib is the standard first-line treatment for HCC. No sufficient data exists regarding its efficacy in the Egyptian population being a costly medication that is not endorsed by insurance and hence is not used in most institutions. Th
Externí odkaz:
https://doaj.org/article/0ce21cff2cdc49c4b346260ff993f749
Autor:
Abdel Rahman El-Naggar, Mohammed F. El-Yamany, Dalia K Zaafar, Soha Osama Hassanin, Hekma A. Abdel-Latif, Atef Bassyouni
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics. 24:254-261
Background: Several trials have reported that dipeptidyl peptidase-4 (DPP-4) inhibitors are used to improve endothelial function in addition to treating type 2 diabetes (T2DM). The current study investigated the effects of vildagliptin, DPP-4 inhibit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5999447b8a67ec470e35328c848d74f9
https://doi.org/10.1177/1074248418817345
https://doi.org/10.1177/1074248418817345
Autor:
Mahitab Hany Hamouda, Manal El-Hamamsy, Nancy Samir Elbarbary, Eman Abdel Rahman Ismail, Abdel Rahman El-Naggar
Publikováno v:
Pediatric diabetes. 19(3)
Background and Objectives Oxidative stress is a significant contributor to the pathogenesis of diabetic nephropathy. Carnosine is a natural radical oxygen species scavenger. We investigated the effect of carnosine as an adjuvant therapy on urinary al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8830140707275d86f665616097d9c7ad
https://pubmed.ncbi.nlm.nih.gov/28744992
https://pubmed.ncbi.nlm.nih.gov/28744992